One small thing I am watching for is something Tahlia Tuck told me in a phone call a few weeks ago: that at some point, we'd see the studies gradually be put back on the website. That would be a good signal. I am still trying to figure out if we could get any news on the Alzheimer's study that will be complete in Feb 2015. As I understand it, each participant is only in the study for three months. Since it is ongoing (still accepting new participants,acc. to clinicaltrials.gov) maybe they do have some type of partial results. I do not know how that works.
Or is it Talhia? I always put the "h" in the wrong place but I know it's not Taliah!
The Clinical Trial (Evaluating the Dietary Supplement Anatabloc in Thyroid Health-ASAP) was completed more than a year ago.
A success would to the releasing of favorable results on the follow-up of participants in the Clinical Trial. If these results are good enough this could be a real game changer. The timing of the action by the FDA has led me to think the FDA may already know what the follow-up results are.
How greedy can the longs be. IMO this stock is already a success. You have a company run-rating at 10 million in sales a year with a market cap of 126.7 million. How much more do you want?
News 
Market Data 
Discover 
AI
